Say goodbye to clinic visits: NOWDiagnostics’ FDA-approved syphilis test is here!
NOWDiagnostics, Inc. (NOWDx) has made a groundbreaking advance in diagnostic testing with the recent approval from the U.S. Food and Drug Administration (FDA) for its ... Read More
Game-changing MRI technology: Zynext Ventures bets big on Neuro42’s brain imaging
Zynext Ventures USA LLC, the venture capital arm of Zydus Lifesciences, has made a significant investment in Neuro42 Inc., a US-based company specialising in advanced ... Read More
Human Parvovirus B19: Understanding its rising impact on public health
Human parvovirus B19, discovered in the 1970s, has become a significant concern in public health, particularly due to its ability to cause severe complications in ... Read More
The silent killer after transplant: What you need to know about graft-versus-host disease
Understanding Graft-Versus-Host Disease (GVHD) Graft-versus-host disease (GVHD) is a severe complication that can occur after an allogeneic stem cell or bone marrow transplant. This condition ... Read More
Mpox in Africa: The untold story of a continent’s struggle against a growing threat
Current prevalence and trends of Mpox in Africa Mpox, also known as Monkeypox, has been a recurring health issue in Africa. Prevalence trends show that ... Read More
Stryker to acquire care.ai to enhance healthcare IT and smart room technologies
Stryker Corporation (NYSE: SYK), a prominent global leader in medical technologies, has announced a definitive agreement to acquire care.ai, a private company known for its ... Read More
Shock deal! Carlyle to snap up Baxter’s kidney care business for $3.8bn—Here’s why it matters
In a landmark move for the medtech industry, Carlyle Group (NASDAQ) has announced its decision to acquire Baxter International Inc.'s (NYSE) Kidney Care segment for ... Read More
MediPortal unveils advanced AI platform for Australian medical practices
MediPortal PTY LTD. has launched a revolutionary AI-powered practice intelligence platform designed to transform medical practice management across Australia and New Zealand. This groundbreaking software, ... Read More
Pantai Hospital Kuala Lumpur launches outpatient parenteral antimicrobial therapy for enhanced patient care
Pantai Hospital Kuala Lumpur (PHKL) has unveiled its new Outpatient Parenteral Antimicrobial Therapy (OPAT) service, a significant advancement in outpatient care designed to improve patient ... Read More
How Metropolis Healthcare achieved a stunning revenue growth in Q1 FY25
Metropolis Healthcare Limited (NSE: METROPOLIS | BSE: 542650), a leading diagnostic chain in India, has announced a significant financial milestone with a 13.1% year-on-year increase ... Read More